Array Biopharma, Inc. (ARRY) Reports Q2 Loss of 17c/Share
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $6.97 -2.79%
EPS Growth %: -52.0%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
CRMT, More
EPS Growth %: -52.0%
Financial Fact:
General and administrative: 7.86M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Array Biopharma, Inc. (NASDAQ: ARRY) reported Q2 EPS of ($0.17), $0.10 better than the analyst estimate of ($0.27).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Array Technologies (ARRY) PT Lowered to $10 at Jefferies, 'Playing Offense Amid Preferred Anxiety'
- Wells Fargo Assumes Array Technologies (ARRY) at Equal Weight
- Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
